Drug survival of adalimumab and infliximab in hidradenitis suppurativa patients: a daily practice cohort study

被引：0
|
作者：
Prens, Lisette M. [1 ]
Bouwman, Klasiena [1 ]
Aarts, Pim [2 ]
Arends, Suzanne [3 ]
van Straalen, Kelsey R. [2 ]
Dudink, Koen [2 ]
van der Zee, Hessel H. [2 ]
Prens, Errol P. [2 ]
Horvath, Barbara [1 ]
机构：
[1] Univ Med Ctr Groningen, Dermatol, Groningen, Netherlands
[2] Univ Med Ctr Rotterdam, Dermatol, Rotterdam, Netherlands
[3] Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
50
引用
下载
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [21] Measuring treatment response to adalimumab in hidradenitis suppurativa patients: An observational study
    Kok, Yonatan
    Nicolopoulos, Jenny
    Braue, Anna
    Kern, Johannes S.
    Varigos, George
    Dolianitis, Con
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2020, 61 (03) : 292 - 294
  • [22] Adalimumab long-term survival in patients with moderate-to-severe hidradenitis suppurativa
    Vilarrasa, Eva
    Lopez-Llunell, Cristina
    Agut-Busquet, Eugenia
    Bittencourt, Flavia
    Puig, Luis
    Romani De Gabriel, Jorge
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 90 - 90
  • [23] Measuring treatment response to adalimumab in hidradenitis suppurativa patients
    Kok, Y.
    Nicolopoulos, J.
    Dolianitis, C.
    Braue, A.
    Varigos, G.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 52 - 52
  • [24] Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving Adalimumab
    Gunter, Simon J.
    Holcomb, Zachary E.
    Lam, Barbara D.
    Porter, Martina L.
    Kimball, Alexa B.
    JAMA DERMATOLOGY, 2024, 160 (06) : 678 - 681
  • [25] Quality of life in patients with hidradenitis suppurativa treated with adalimumab
    Pantelidi, Kleoniki
    Agiasofitou, Efthymia
    Marnelakis, Ioannis
    Kapsiocha, Anastasia
    Liakou, Aikaterini I.
    Rotsiamis, Nikolaos
    Kontochristopoulos, Georgios
    Rigopoulos, Dimitris
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 50 - 50
  • [26] Efficacy of adalimumab in hidradenitis suppurativa at week 12 in clinical practice: Spanish multicenter study
    Martorell, Antonio
    Romani, Jorge
    Bassas, Juli
    Vilarrasa, Eva
    Diaz, Rosa
    Carlos Pascual, Jose
    Martin-Ezquerra, Gemma
    Manuel Segura, Jose
    Ruiz-Villaverde, Ricardo
    Mendieta, Marta
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB123 - AB123
  • [27] Infliximab for hidradenitis suppurativa: report of seven consecutive patients
    Dupuy, A
    Fardet, L
    Kerob, D
    Levy, A
    Bachelez, H
    Morel, P
    Lebbe, C
    EXPERIMENTAL DERMATOLOGY, 2006, 15 (06) : 482 - 482
  • [28] Efficacy of infliximab treatment in patients with severe Hidradenitis Suppurativa
    Elkjaer, M.
    Dinesen, L.
    Benazzato, L.
    Jess, T.
    Riis, L.
    Caspersen, S.
    Rodriguez, San Pio J.
    Logager, V
    Munkholm, P.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (05) : 661 - 661
  • [29] Variable response of hidradenitis suppurativa to infliximab in four patients
    Usmani, N.
    Clayton, T. H.
    Everett, S.
    Goodfield, M. D. J.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) : 204 - 205
  • [30] Pharmaceutical Benefits Scheme listing of adalimumab for hidradenitis suppurativa: Is hidradenitis suppurativa a life-changing drug or does lifestyle change the drug?
    Vekic, Dunja A.
    Frew, John W.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 (03) : E243 - E244
12345